These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20027650)

  • 1. Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease.
    Ippoliti A; Devlin S; Mei L; Yang H; Papadakis KA; Vasiliauskas EA; McGovern DP; Abreu MT; Melmed G; Shaye O; Enayati P; Chen G; Choi J; Taylor K; Landers CJ; Rotter JI; Targan SR
    Inflamm Bowel Dis; 2010 Aug; 16(8):1279-85. PubMed ID: 20027650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
    Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
    Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
    Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
    Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.
    Devlin SM; Yang H; Ippoliti A; Taylor KD; Landers CJ; Su X; Abreu MT; Papadakis KA; Vasiliauskas EA; Melmed GY; Fleshner PR; Mei L; Rotter JI; Targan SR
    Gastroenterology; 2007 Feb; 132(2):576-86. PubMed ID: 17258734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
    Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
    Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
    Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
    Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.
    Murdoch TB; Xu W; Stempak JM; Landers C; Targan SR; Rotter JI; Silverberg MS
    Inflamm Bowel Dis; 2012 Sep; 18(9):1743-8. PubMed ID: 22275320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations.
    Schnitzler F; Friedrich M; Wolf C; Stallhofer J; Angelberger M; Diegelmann J; Olszak T; Tillack C; Beigel F; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2015; 10(7):e0116044. PubMed ID: 26147989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior.
    Lichtenstein GR; Targan SR; Dubinsky MC; Rotter JI; Barken DM; Princen F; Carroll S; Brown M; Stachelski J; Chuang E; Landers CJ; Stempak JM; Singh S; Silverberg MS
    Inflamm Bowel Dis; 2011 Dec; 17(12):2488-96. PubMed ID: 21391291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants.
    Glas J; Seiderer J; Tillack C; Pfennig S; Beigel F; Jürgens M; Olszak T; Laubender RP; Weidinger M; Müller-Myhsok B; Göke B; Ochsenkühn T; Lohse P; Diegelmann J; Czamara D; Brand S
    PLoS One; 2010 Dec; 5(12):e14466. PubMed ID: 21209938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.
    Heliö T; Halme L; Lappalainen M; Fodstad H; Paavola-Sakki P; Turunen U; Färkkilä M; Krusius T; Kontula K
    Gut; 2003 Apr; 52(4):558-62. PubMed ID: 12631669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
    Schnitzler F; Friedrich M; Wolf C; Angelberger M; Diegelmann J; Olszak T; Beigel F; Tillack C; Stallhofer J; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2014; 9(11):e108503. PubMed ID: 25365249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.
    Abreu MT; Taylor KD; Lin YC; Hang T; Gaiennie J; Landers CJ; Vasiliauskas EA; Kam LY; Rojany M; Papadakis KA; Rotter JI; Targan SR; Yang H
    Gastroenterology; 2002 Sep; 123(3):679-88. PubMed ID: 12198692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis.
    Adler J; Rangwalla SC; Dwamena BA; Higgins PD
    Am J Gastroenterol; 2011 Apr; 106(4):699-712. PubMed ID: 21343918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistatic interaction between TLR4 and NOD2 in patients with Crohn's Disease: relation with risk and phenotype in a Spanish cohort.
    Martinez-Chamorro A; Moreno A; Gómez-García M; Cabello MJ; Martin J; Lopez-Nevot MÁ
    Immunobiology; 2016 Sep; 221(9):927-33. PubMed ID: 27290609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.
    Tolentino YF; Elia PP; Fogaça HS; Carneiro AJ; Zaltman C; Moura-Neto R; Luiz RR; Carvalho Mda G; de Souza HS
    Dig Dis Sci; 2016 Sep; 61(9):2636-47. PubMed ID: 27107867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.
    Cantó E; Ricart E; Busquets D; Monfort D; García-Planella E; González D; Balanzó J; Rodriguez-Sanchez JL; Vidal S
    World J Gastroenterol; 2007 Nov; 13(41):5446-53. PubMed ID: 17907287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NOD2 gene mutation in Moroccan patients with Crohn's disease: prevalence, genotypic study and correlation of NOD2 gene mutation with the phenotype of Crohn's disease].
    Tamzaourte M; Errabih I; Krami H; Maha F; Maria L; Benzzoubeir N; Ouazzani L; Sefiani A; Ouazzani H
    Pan Afr Med J; 2017; 27():116. PubMed ID: 28819537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.